Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 7/20 | 0.41 |
| ▸ | MMP1 | P03956 | 3/20 | 0.41 |
| ▸ | CA1 | P00915 | 3/20 | 0.41 |
| ▸ | MMP2 | P08253 | 2/20 | 0.41 |
| ▸ | MMP9 | P14780 | 2/20 | 0.41 |
| ▸ | MMP8 | P22894 | 2/20 | 0.41 |
| ▸ | MMP13 | P45452 | 2/20 | 0.41 |
| ▸ | F2 | P00734 | 3/20 | 0.40 |
| ▸ | PRSS1 | P07477 | 3/20 | 0.40 |
| ▸ | PRSS2 | P07478 | 3/20 | 0.40 |
| ▸ | PRSS3 | P35030 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | HTT | P42858 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10787889 | 0.85 | MMP2 (0.47) | CA2MMP1MMP2MMP9MMP13 | |
| SCHEMBL10700258 | 0.85 | LMNA (0.45) | CA2MMP1MMP2MMP8MMP13 | |
| SCHEMBL25986733 | 0.84 | ALDH1A1 (0.40) | MMP2MMP9F2PRSS1PRSS2 | |
| SCHEMBL8818862 | 0.81 | CA2 (0.39) | CA2MMP1MMP2MMP8MMP13 | |
| SCHEMBL314732 | 0.81 | TSHR (0.50) | CA2MMP1CA1MMP2MMP9 | |
| SCHEMBL2685459 | 0.81 | ALDH1A1 (0.60) | ALDH1A1KMT2AMEN1LMNAGAA | |
| SCHEMBL1171141 | 0.81 | HSD11B1 (0.50) | MMP1MMP2MMP8MMP13ALDH1A1 | |
| SCHEMBL25986473 | 0.80 | SMN1; SMN2 (0.38) | CA2CA1ALDH1A1HTTLMNA | |
| SCHEMBL9780984 | 0.79 | PSIP1 (0.55) | CA2CA1MMP2MMP9MMP8 | |
| SCHEMBL10766564 | 0.79 | HTT (0.61) | CA2MMP1CA1MMP2MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2861673-B1 | METAL FREE REACTIVE DYES, PROCESS FOR THE PRODUCTION THEREOF AND THEIR USE | DYSTAR COLOURS DISTRIB GMBH (DE) | 2023-08-09 | — | — | EP | disclosed |
| US-11155568-B2 | Bioadhesives | NUTECH VENTURES (US) | 2021-10-26 | — | — | US | disclosed |
| US-20200095270-A1 | METHODS OF MAKING AND USING LIGNIN DERIVATIVES | NUTECH VENTURES | 2020-03-26 | — | — | US | disclosed |
| US-20180037598-A1 | METHODS OF MAKING AND USING LIGNIN DERIVATIVES | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 2018-02-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11155568-B2 | Bioadhesives | EPCAM, VCAM1, SELP | CA2 4351/4885MMP1 370/4885CA1 3594/4885 |
| US-20200095270-A1 | METHODS OF MAKING AND USING LIGNIN DERIVATIVES | HLCS, LOX, DCXR | CA2 4569/4885MMP1 258/4885CA1 3925/4885 |
| US-20180037598-A1 | METHODS OF MAKING AND USING LIGNIN DERIVATIVES | HLCS, LOX, DCXR | CA2 4569/4885MMP1 258/4885CA1 3925/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.